Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.10.31
2016年第三季度报告正文的更正公告
2016.10.29
关于公司发行公司债券申请获中国证券监督管理委员会核准的公告
2016.10.19
关于关联方获得欧盟药政批准的公告
2016.09.29
关于公司使用自有资金购买低风险理财产品的进展公告
2016.09.21
第三届监事会第十八次会议决议公告
2016.09.21
关于对全资子公司海普瑞（香港）有限公司进行增资的公告
2016.09.21
第三届董事会第二十六次会议决议公告
2016.09.21
关于全资子公司对ORI Healthcare Fund, L.P.追加投资的公告
2016.09.21
关于向银行申请授信的公告
2016.09.19
2016年第二次临时股东大会的法律意见书
第一页
上一页
86
87
88
89
90
下一页
最后一页
